# Genepoint Biological Technology (China) Co

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genepoint-biological-technology-china-co

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.genepoint.cn
- Total disclosed funding: $67M
- Latest round: Series D (Jan 18, 2023)
- Investors on record: 13

## About

Based in Shanghai, China and established in 2015, Genepoint Biological Technology (China) Co, Ltd is a technology company that focuses on researching and developing cryogenic biomaterial storage systems. The company's R&D center is in Chengdu. 

The company focuses on intelligent biological deep cryogenic storage system solutions, including automated storage for cryo-bio material, cryogenic cold chain logistics, data management and biobank turn-key project, and the cryogenic storage of hybrid energy. The automated cryogenic storage system, KIOSK, of which the operating area can be completely isolated from the storage area, and the robotic arm can directly pick the pipe at -80°C. Besides, the company also provides nitrogen preservation series, deep cryogenic transport robots, and cryogenic tube picking workstations.

## Funding rounds

- Series D, Jan 18, 2023, $29M — Golden China Fund, LYFE Capital, DYEE Capital, Shanghai Growth Investment, Guolian Tongbao Capital, BIO-TOWN Capital, Beijing Guangda Huitong Engineering Research Institute
- Series C, Feb 7, 2022, $19M — LYFE Capital, DYEE Capital
- Series C, Jun 9, 2021, $19M — NLVC, Legend Star, DYEE Capital, HosenCare Brothers
- Series A, Oct 21, 2018 — Tianyi Investment Group
- Series A, Aug 24, 2018 — Shanghai China Healthcare Venture Management
- Angel, Feb 28, 2018 — BMC

## Investors

- BMC (https://capitalatlas.ai/funds/bmc) — Angel
- Shanghai China Healthcare Venture Management (https://capitalatlas.ai/funds/shanghai-china-healthcare-venture-management) — Series A
- Tianyi Investment Group (https://capitalatlas.ai/funds/tianyi-investment-group) — Series A
- NLVC (https://capitalatlas.ai/funds/nlvc) — Series C
- Legend Star (https://capitalatlas.ai/funds/legend-star) — Series C
- DYEE Capital (https://capitalatlas.ai/funds/dyee-capital) — Series C, Series D
- HosenCare Brothers (https://capitalatlas.ai/funds/hosencare-brothers) — Series C
- LYFE Capital — Series C, Series D
- Golden China Fund (https://capitalatlas.ai/funds/golden-china-fund) — Series D
- Shanghai Growth Investment (https://capitalatlas.ai/funds/shanghai-growth-investment) — Series D
- Guolian Tongbao Capital (https://capitalatlas.ai/funds/guolian-tongbao-capital) — Series D
- BIO-TOWN Capital (https://capitalatlas.ai/funds/bio-town-capital) — Series D
- Beijing Guangda Huitong Engineering Research Institute — Series D